Teralys Capital

Teralys Capital, established in 2009 and headquartered in Montreal, Canada, is a fund of funds management firm specializing in venture capital investments. The company primarily invests in Canadian venture capital and growth-oriented funds, with a focus on information technology, life sciences, and cleantech sectors. Teralys Capital allocates a significant portion of its capital to early-stage companies and also invests in growth, expansion, and technology buyout funds. The firm's investment strategy includes a mix of direct fund investments and secondary market transactions, with a preference for Canadian-based funds, particularly those from Quebec.

Jacques Bernier

Managing Partner

Cédric Bisson MD

Venture Partner

Beatrice Couture

Principal

Luc Couture

Partner

Éric Legault

Co-Founder and Managing Partner

Julie Prévost

Finance Partner

Past deals in Ottawa

Turnstone Biologics

Series D in 2021
Turnstone Biologics is a clinical-stage biotechnology company focused on developing viral immunotherapies to improve cancer survival. Its lead candidate, RIVAL-01, combines three immunomodulators to stimulate immune activity and reprogram the tumor microenvironment.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.